发明名称 Bicyclic Heteroaromatic Compounds
摘要 A compound of formula (I) wherein: R<SUP>1 </SUP>is an aryl group, unsubstituted or substituted by 1, 2, 3 or 4 substituents which may be the same or different selected from the group consisting of C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl, C<SUB>1</SUB>-C<SUB>6 </SUB>alkoxy, C<SUB>1</SUB>-C<SUB>6 </SUB>alkylthio, aryl C<SUB>1</SUB>-C<SUB>6 </SUB>alkoxy, hydroxy, halo, CN, COR<SUP>6</SUP>, COOR<SUP>6</SUP>, NR<SUP>6</SUP>COR<SUP>7</SUP>, CONR<SUP>8</SUP>R<SUP>9</SUP>, SO<SUB>2</SUB>NR<SUP>8</SUP>R<SUP>9</SUP>, NR<SUP>6</SUP>SO<SUB>2</SUB>R<SUP>7</SUP>, NR<SUP>8</SUP>R<SUP>9</SUP>, halo C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, and halo C<SUB>1</SUB>-C<SUB>4 </SUB>alkoxy; W is CH and X is N, or W is N and X is CH, or W and X are CH; Y is C<SUB>2</SUB>-C<SUB>4</SUB>alkyl, R<SUP>2 </SUP>is hydrogen, C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl, C<SUB>1</SUB>-C<SUB>6 </SUB>alkoxy, C<SUB>1</SUB>-C<SUB>6 </SUB>alkylthio, aryl C<SUB>1</SUB>-C<SUB>6 </SUB>alkoxy, hydroxy, halo, CN, COR<SUP>6</SUP>, carboxy, COOR<SUP>6</SUP>, NR<SUP>6</SUP>COR<SUP>7</SUP>, CONR<SUP>8</SUP>R<SUP>9</SUP>, SO<SUB>2</SUB>NR<SUP>8</SUP>R<SUP>9</SUP>, NR<SUP>6</SUP>SO<SUB>2</SUB>R<SUP>7</SUP>, NR<SUP>8</SUP>R<SUP>9</SUP>, mono to perfluoro-C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl, or mono to perfluoro-C<SUB>1</SUB>-C<SUB>6 </SUB>alkoxy; n is 0-5; R<SUP>3 </SUP>is C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl; R<SUP>4 </SUP>is C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl; R<SUP>5 </SUP>is hydrogen, C<SUB>1</SUB>-C<SUB>10 </SUB>alkyl, C<SUB>2</SUB>-C<SUB>10 </SUB>alkenyl, C<SUB>2</SUB>-C<SUB>10 </SUB>alkynyl, halo C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, C<SUB>3</SUB>-C<SUB>8 </SUB>cycloalkyl, C<SUB>3</SUB>-C<SUB>8 </SUB>cycloalkyl, C<SUB>3</SUB>-C<SUB>8 </SUB>cycloalkyl C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, C<SUB>5</SUB>-C<SUB>8</SUB>cycloalkenyl, C<SUB>5</SUB>-C<SUB>8</SUB>cycloalkenyl C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, 3-8-membered heterocycloalkyl, 3-8-membered heterocycloalkyl C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, C<SUB>6</SUB>-C<SUB>14 </SUB>aryl, C<SUB>6</SUB>-C<SUB>14 </SUB>aryl C<SUB>1</SUB>-C<SUB>10 </SUB>alkyl, heteroaryl, or heteroaryl C<SUB>1</SUB>-C<SUB>10</SUB>alkyl; wherein each group is optionally one or more times by the same and/or a different group which is C<SUB>1</SUB>-C<SUB>6 </SUB>alkoxy, C<SUB>1</SUB>-C<SUB>6 </SUB>alkylthio, aryl C<SUB>1</SUB>-C<SUB>6 </SUB>alkoxy, hydroxy, halo, CN, NR<SUP>8</SUP>R<SUP>9</SUP>, or halo C<SUB>1</SUB>-C<SUB>4 </SUB>alkoxy R<SUP>6 </SUP>and R<SUP>7 </SUP>are independently hydrogen or C<SUB>1</SUB>-C<SUB>10 </SUB>alkyl; R<SUP>8 </SUP>and R<SUP>9 </SUP>are the same or different and are hydrogen or C<SUB>1</SUB>-C<SUB>10 </SUB>alkyl, or R<SUP>9 </SUP>and R<SUP>10 </SUP>together with the nitrogen to which they are attached form a 5- to 7 membered ring optionally containing one or more further heteroatoms selected from oxygen, nitrogen and sulphur, and optionally substituted by one or two substituents selected from the group consisting of hydroxy, oxo, C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl, C<SUB>1</SUB>-C<SUB>4 </SUB>alkylcarboxy, aryl, and aryl C<SUB>1</SUB>-C<SUB>4 </SUB>alkyl; or a pharmaceutically acceptable salt thereof. These compounds are useful for treating atherosclerosis or other inflammatory diseases.
申请公布号 US2008090853(A1) 申请公布日期 2008.04.17
申请号 US20070626882 申请日期 2007.01.25
申请人 LEACH COLIN ANDREW 发明人 LEACH COLIN ANDREW
分类号 A61K31/517;A61K31/4427;C07D471/04 主分类号 A61K31/517
代理机构 代理人
主权项
地址